<DOC>
	<DOC>NCT00241059</DOC>
	<brief_summary>The objective of this extension study is to allow patients being treated with enteric-coated mycophenolate sodium (core study CERL080A2405LA01) to continue on the same treatment and to assess the long-term safety of EC-MPS.</brief_summary>
	<brief_title>Extension Study of the Safety and Efficacy of Enteric-coated Mycophenolate Sodium in Kidney Transplant Recipients</brief_title>
	<detailed_description />
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<criteria>All patients who completed study CERL080A2405LA01 and who are willing to continue treatment with EntericCoated Mycophenolate Sodium. Other protocoldefined inclusion / exclusion criteria may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>Renal transplantation, maintenance patients, tolerability, EC-MPS</keyword>
</DOC>